These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14509754)

  • 21. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone, gender and face shape in Prader-Willi syndrome.
    de Souza MA; McAllister C; Suttie M; Perrotta C; Mattina T; Faravelli F; Forzano F; Holland A; Hammond P
    Am J Med Genet A; 2013 Oct; 161A(10):2453-63. PubMed ID: 23918156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An obese female with Prader-Willi syndrome and daytime sleepiness.
    Wagner MH; Berry RB
    J Clin Sleep Med; 2007 Oct; 3(6):645-7. PubMed ID: 17993048
    [No Abstract]   [Full Text] [Related]  

  • 24. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children.
    Tauber M; Barbeau C; Jouret B; Pienkowski C; Malzac P; Moncla A; Rochiccioli P
    Horm Res; 2000; 53(6):279-87. PubMed ID: 11146368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial Effects of Long-Term Growth Hormone Treatment on Adaptive Functioning in Infants With Prader-Willi Syndrome.
    Lo ST; Festen DA; Tummers-de Lind van Wijngaarden RF; Collin PJ; Hokken-Koelega AC
    Am J Intellect Dev Disabil; 2015 Jul; 120(4):315-27. PubMed ID: 26161469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prader-Willi syndrome and sleep-disordered breathing.
    Miller J; Wagner M
    Pediatr Ann; 2013 Oct; 42(10):200-4. PubMed ID: 24126982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children.
    Hauffa BP; Petersenn S
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):155-6. PubMed ID: 19178506
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
    Cohen M; Harrington J; Narang I; Hamilton J
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth Hormone Treatment for Prader-Willi Syndrome.
    Tauber M; Diene G; Molinas C
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):91-99. PubMed ID: 30378786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden death in growth hormone-treated children with Prader-Willi syndrome.
    Van Vliet G; Deal CL; Crock PA; Robitaille Y; Oligny LL
    J Pediatr; 2004 Jan; 144(1):129-31. PubMed ID: 14722532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome?
    Eiholzer U; Malich S; I'Allemand D
    Eur J Pediatr; 2000 Apr; 159(4):299. PubMed ID: 10789939
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome.
    Böhm B; Ritzén EM; Lindgren AC
    Acta Paediatr; 2015 Jan; 104(1):59-67. PubMed ID: 25263744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of growth hormone in children and adolescents].
    Bergadá I
    Medicina (B Aires); 2013; 73(3):272-6. PubMed ID: 23732208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
    Bakker B; Maneatis T; Lippe B
    Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prader-Willi syndrome].
    Sarda P
    Soins Pediatr Pueric; 2013; (274):20-3. PubMed ID: 24228330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone therapy in Prader-Willi syndrome.
    Davies PS
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):2-7. PubMed ID: 11244451
    [No Abstract]   [Full Text] [Related]  

  • 37. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
    Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome.
    Khare M; Gold JA; Wencel M; Billimek J; Surampalli A; Duarte B; Pontello A; Galassetti P; Cassidy S; Kimonis VE
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):511-8. PubMed ID: 24515997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.
    Miller J; Silverstein J; Shuster J; Driscoll DJ; Wagner M
    J Clin Endocrinol Metab; 2006 Feb; 91(2):413-7. PubMed ID: 16317059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.